Navigation Links
CytRx Announces RNAi Delivery Nanoparticle Technology Exclusively,Licensed to Subsidiary, RXi Pharmaceuticals, Described in,Peer-Reviewed Journal

than historical facts) as defined in the Private Securities Litigation Reform Act of 1995 and in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements involve risks and uncertainties that could cause actual events or results to differ materially from the events or results described in the forward looking statements. Examples of such risks and uncertainties include, but are not limited to, RXi's need to raise significant capital to fund operations and development of its potential products, the need to establish management and other infrastructure for the RXi subsidiary, intense competition with other companies focused on RNAi and other larger companies with RNAi programs and with other existing or new therapeutic modalities, the early stage of development of RXi's technology, and the scope, timing and outcome of pre-clinical and clinical testing and regulatory review of RXi's potential products. Additional risks or uncertainties are described in CytRx's most recently filed SEC documents, such as its most recent annual report on Form 10-K, all quarterly reports on Form 10-Q and any current reports on Form 8-K filed since the date of the last Form 10-K. All forward-looking statements are based upon information available to CytRx on the date the statements are first published. CytRx undertakes no obligation to publicly update or revise any forward- looking statements, whether as a result of new information, future events or otherwise.

Contact

CytRx Corporation
CEOcast, Inc.
Dan Schustack, 212-732-4300
dschustack@ceocast.com


'"/>




Page: 1 2 3 4

Related medicine technology :

1. CytRx Reports Promising Data from Its Open-Label Extension Clinical Trial of Arimoclomol in ALS
2. CytRx Announces Clinical Results from Its Rising Multiple Dose Trial with Arimoclomol for ALS
3. CytRx Announces Positive Results of Arimoclomol in Preclinical Stroke Recovery Studies
4. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
5. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
7. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
8. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
9. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
10. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
11. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
Post Your Comments:
(Date:7/1/2015)... FT LAUDERDALE, Florida , July 1, 2015 ... and marketer of innovative medical devices for the treatment of ... prevailed in a final opposition appeal hearing in the European ... - STENT HAVING HELICAL ELEMENTS (,482). The ,482 patent has ... has been upheld as a valid patent in amended form. ...
(Date:7/1/2015)... COTTONWOOD HEIGHTS, Utah , July 1, 2015 ... DYNT ), a manufacturer and marketer of rehabilitation ... has completed its $4,025,000 private placement financing led ... a strategic private equity investor focused on the ... capital to promote organic growth and pursue potential ...
(Date:7/1/2015)... SAN DIEGO , July 1, 2015  MEI Pharma, ... the clinical development of novel therapies for cancer, announced today ... Executive Officer, will present at the inaugural Cantor Fitzgerald Healthcare ... time from Le Parker Meridien in ... can be accessed at www.meipharma.com . A replay will ...
Breaking Medicine Technology:OrbusNeich Announces Favorable Ruling from the European Patent Office and Initiation of Litigation Against Terumo Corporation 2Dynatronics Announces Completion Of $4,025,000 Private Placement Led By Prettybrook Partners 2Dynatronics Announces Completion Of $4,025,000 Private Placement Led By Prettybrook Partners 3MEI Pharma to Present at Cantor Fitzgerald Healthcare Conference 2
... IBD Using Serology Testing Also Presented , , ... specialty pharmaceutical and diagnostic company, announced new findings regarding ... the detection of Crohn,s disease and particular genetic markers ... oral presentation yesterday at Digestive Disease Week (DDW) in ...
... , , ORLANDO, Fla., June 1 Scientists ... presented data demonstrating the feasibility of long-term, low-dose adjuvant ... metastases in patients with locally advanced head and neck ... at the 2009 American Society of Clinical Oncology Annual ...
Cached Medicine Technology:Prometheus Announces New Findings Regarding Patients at Risk for Celiac Disease at DDW 2Prometheus Announces New Findings Regarding Patients at Risk for Celiac Disease at DDW 3Researchers at the Karmanos Cancer Institute in Detroit Discover Feasibility of Chemotherapy Alternative 2Researchers at the Karmanos Cancer Institute in Detroit Discover Feasibility of Chemotherapy Alternative 3
(Date:7/1/2015)... , ... July 01, 2015 , ... ... Biomedical Sciences at Georgia State University and a Georgia Research Alliance Eminent Scholar ... develop novel anti-inflammatory therapeutics against middle-ear infections. , The grant from the National ...
(Date:7/1/2015)... ... July 01, 2015 , ... There is ... Americans have been arguing over laws governing sexuality since the first Pilgrims landed ... forthcoming historical comparative biography by Cindy Safronoff reveals. Crossing Swords: Mary Baker Eddy ...
(Date:7/1/2015)... ... 2015 , ... A healthy eating plan concentrates on foods ... organic foods and products can help limit the exposure to pesticides and chemical-based ... farming. Choosing home raised chickens and eggs that do not contain antibiotics are ...
(Date:7/1/2015)... ... July 01, 2015 , ... Renowned rhinoplasty surgeon and Symposium ... 2016 Dallas Rhinoplasty Symposium . Set for March 6th - 8th, the 2016 meeting ... from the basic training and fundamentals of nasal surgery through the most modern advancements ...
(Date:7/1/2015)... ... July 01, 2015 , ... Did you know that infertility ... Health Month, and we at Advanced Fertility Center of Texas (AFCT) would like to ... , While infertility is often considered to be a “woman’s issue,” male fertility factors ...
Breaking Medicine News(10 mins):Health News:Institute for Biomedical Sciences Researcher Gets $1.6 Million to Develop Anti-Inflammatory Drug 2Health News:Biography by Cindy Safronoff to be Released July 4 Explores an 1870s Marriage Debate Over Women’s Rights and the Implications of the American Revolution for Sexuality 2Health News:Biography by Cindy Safronoff to be Released July 4 Explores an 1870s Marriage Debate Over Women’s Rights and the Implications of the American Revolution for Sexuality 3Health News:Biography by Cindy Safronoff to be Released July 4 Explores an 1870s Marriage Debate Over Women’s Rights and the Implications of the American Revolution for Sexuality 4Health News:Chicken Coop Condo Offer New Chicken Coop Designs 2Health News:Dr. Rod J. Rohrich Announces Dates for 2016 Dallas Rhinoplasty Symposium 2Health News:Dr. Rod J. Rohrich Announces Dates for 2016 Dallas Rhinoplasty Symposium 3Health News:Male Fertility: Improve Testosterone and Fertility With Natural Approaches 2Health News:Male Fertility: Improve Testosterone and Fertility With Natural Approaches 3Health News:Male Fertility: Improve Testosterone and Fertility With Natural Approaches 4
... ... support to the Major League Baseball Players Alumni association to raise ... and auction, helps provide hope and funding for end stage cancer ... and life for cancer patients and their families. Providing financial assistance ...
... ... progress but says there are still too many preventable automobile accidents. , ... New York, NY (PRWEB) April 23, 2010 -- ... become complacent to driving hazards as they hit the highway for a summer vacation road ...
... Cancer is the number-one ... Buffalo are partnering to raise awareness and funds to fight this devastating disease. The goal this ... Foundation to fund research and finding a cure. , ... Wilton, Conn., and San Diego (PRWEB) April 24, 2010 -- Cancer is ...
... He Volunteered ... His Experience to Further the Search for a Cure and Better Treatments for PD. ... (PRWEB) -- “Deep Brain Diary: ... personal story about living with a neurological disease that afflicts over a million Americans. ...
... ... to grow enormously over the next few years and healthcare related jobs ... greater employment opportunities for those individuals educated and trained in any of ... generation will bring with it a strong demand for skilled medical workers, ...
... Groundbreaking move ... data.worldbank.org. , ... April 22, 2010 -- The World Bank Group announced on Tuesday that it has thrown ... to use the data to create new applications and solutions to help poor people in ...
Cached Medicine News:Health News:Major League Baseball Players Alumni Help Lazarex Cancer Foundation Raise Funds 2Health News:Major League Baseball Players Alumni Help Lazarex Cancer Foundation Raise Funds 3Health News:U.S. and New York Car Accident Deaths Continue Steady Decline 2Health News:BLUE Buffalo Pet Food and PETCO Partner to Fight Pet Cancer During Pet Cancer Awareness Month 2Health News:BLUE Buffalo Pet Food and PETCO Partner to Fight Pet Cancer During Pet Cancer Awareness Month 3Health News:BLUE Buffalo Pet Food and PETCO Partner to Fight Pet Cancer During Pet Cancer Awareness Month 4Health News:Parkinson's Disease Patient's Story Goes Multimedia, Proceeds to Benefit PD Research 2Health News:Parkinson's Disease Patient's Story Goes Multimedia, Proceeds to Benefit PD Research 3Health News:Parkinson's Disease Patient's Story Goes Multimedia, Proceeds to Benefit PD Research 4Health News:Prospective Healthcare Workers: Fully Accredited Healthcare Degree Programs Are Now Offered Through OnlineEducation.com 2Health News:Prospective Healthcare Workers: Fully Accredited Healthcare Degree Programs Are Now Offered Through OnlineEducation.com 3Health News:Prospective Healthcare Workers: Fully Accredited Healthcare Degree Programs Are Now Offered Through OnlineEducation.com 4Health News:Prospective Healthcare Workers: Fully Accredited Healthcare Degree Programs Are Now Offered Through OnlineEducation.com 5Health News:World Bank Group Opens Data to All 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: